Jeju Creative Economy Innovation Center (Director Lee Byeong-seon, hereinafter referred to as Jeju Center) announced that digital healthcare startup Indream Healthcare (CEO Kang Byeong-ju) signed a business agreement with Jeju National University Hospital and will introduce InDream MediSupport, a multi-drug management solution. This agreement aims to build a safe future medical environment.
The signing ceremony was held at Jeju National University Hospital on the 26th of last month, and was attended by Indream Healthcare representatives and hospital officials. According to the agreement, Indream Healthcare will integrate its MediSupport system with Jeju National University Hospital’s electronic medical record (EMR) to support medical staff in analyzing drug interactions and side effects in real time.
InDream MediSupport is a multi-drug management solution that helps medical professionals make prescription decisions, providing real-time information on drug interactions and side effects. InDream MyChart is a mobile app that allows patients to manage their prescription history and medication information.
The linkage of the two systems is expected to maximize the effectiveness of treatment by strengthening cooperation between medical staff and patients. Medical staff can make safe prescription decisions using MediSupport data, and patients can easily manage their health information with MyChart.
“The integration of MediSupport and MyChart provides great value to both patients and medical staff,” said Kang Byung-joo, CEO of Indream Healthcare. “We look forward to the successful operation of this solution at Jeju National University Hospital.”
With the introduction of MediSupport and MyChart from Indream Healthcare, Jeju National University Hospital expects to prevent medication prescription errors and increase treatment efficiency. The two systems are expected to provide a safe and reliable medical environment for local patients.
Meanwhile, Jeju Center discovered Indream Healthcare in 2023 through the Start-Be Acceleration Program. Indream Healthcare's CEO, Kang Byung-joo, is a medical expert who graduated from Yonsei University College of Medicine, completed his residency and specialist course in internal medicine and rheumatology at Seoul Asan Medical Center, and is currently an associate professor at Jeju National University College of Medicine. CEO Kang received the Minister of Health and Welfare Award and the Minister of Science and ICT Award in 2022 for his creative ideas and technology development in medicine and polypharmacy management.
- See more related articles
You must be logged in to post a comment.